Postdoctoral Fellowship Opportunity in Addiction Science

 

Outstanding interdisciplinary fellowship positions are through a NIDA-funded institutional training grant, a newly-funded translational research center and research grants held by individual faculty. Areas of training span basic and translational initiatives in drug abuse and addiction; drug discovery and medications development in addiction, pain management and infectious disease; fetal exposure to medications during pregnancy in opiate addicts; HIV/AIDS associated neuropathy and interactions between HIV and drug addiction. Fellows will be mentored to facilitate transition to independent research careers by emphasizing the acquisition of suitable laboratory, writing, public speaking, teaching and interpersonal skills. Fellows will have access to the resources of a variety of research centers and programs with which the mentors are closely affiliated including the Center for Addiction Research (www.utmb.edu/addiction/) and the Program in Chemical Biology. The goal of the training program is to mentor contemporary scientists equipped with the tools to advance the mechanistic understanding of addiction and move these advances toward new therapeutic approaches to its treatment. All training grant positions are restricted to US citizens or permanent residents.

 

Competitive salary and benefit packages are available. To apply, contact: Dr. Kathryn A. Cunningham (tllandry@utmb.edu), Center for Addiction Research and Department of Pharmacology and Toxicology, University of Texas Medical Branch, 301 University Blvd., Galveston, TX 77555-1031. UTMB is an equal opportunity/affirmative action employer, M/F/D/V.

 

Mahmoud S. Ahmed, Ph.D.

Opiate and nicotine addiction, maternal-fetal pharmacology

Susan M. Carlton, Ph.D.

Glutamate and somatostatin pharmacology; pain and analgesia

Kathryn A. Cunningham, Ph.D.

Psychostimulant neurobiology; serotonin neurotransmission; preclinical addiction models; medications development

Kelly T. Dineley, Ph.D.

Molecular mechanisms of addiction, synaptic plasticity of addictive processes; nicotine addiction

Benjamin B. Gelman, M.D.

Neurochemistry of HIV dementia & neuropathy; interactions of HIV and drug abuse

Scott R. Gilbertson, Ph.D.

Medicinal chemistry for kappa opiate, kainic acid and serotonin; bioorganic chemistry catalysis

James R. Halpert, Ph.D.

Structure and function of mammalian cytochromes P450

Kenneth M. Johnson, Ph.D.

Neuropharmacology, neurotoxicology, PCP, cell death and signaling; medications development

Jose Moron-Concepcion, Ph.D.

Mechanisms of opiate-induced neuroplasticity ; extinction of morphine-dependent conditioned behavior ; learning and memory

Amar Natarajan, Ph.D.

Phospho-specific protein-protein interactions; novel small molecules to perturb these interactions; chemical biology, computational methods

Volker E. Neugebauer, M.D., Ph.D.

Pain and analgesia, affective states; neuroscience of emotional component of pain

Patricia Shinnick-Gallagher, Ph.D.

Membrane mechanisms of learned fear and conditioned cues

Eric M. Smith, Ph.D.

Psychoneuroimmunology of opioids, anabolic steroids

Cheryl S. Watson, Ph.D.

Steroid hormone mechanisms, interactions with dopamine and serotonin transporters; cellular and molecular biology